Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MDG1k | Xetra | EUR | Delayed | |
MDG1d | BATS Europe | EUR | Delayed | |
MDG1k | TradeGate | EUR | Delayed | |
MDG1k | Frankfurt | EUR | Delayed | |
MDG1k | Vienna | EUR | Real-time |
For the fiscal year ended 31 December 2021, MediGene AG revenues increased 26% to EUR11M. Net loss decreased 65% to EUR10M. Revenues reflect Asia segment increase of 98% to EUR5.8M. Lower net loss reflects Other expenses decrease from EUR5.3M (expense) to EUR0K, Labor Cost in R&D decrease of 51% to EUR4.5M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -EUR1.18 to -EUR0.41.
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Revenue | 2.31 | 2.15 | ||
Gross Profit | 1.96 | 1.87 | ||
Operating Income | -2.35 | -3.16 | ||
Net Income | -2.44 | -3.23 |
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Assets | 59.47 | 66.88 | 74.75 | |
Total Liabilities | 14.65 | 17.42 | 21.6 | |
Total Equity | 44.82 | 49.46 | 53.15 |
Period Ending: | Dec 31, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 0 Months | 12 Months |
Cash From Operating Activities | -10.75 | -7.38 | -24.79 | |
Cash From Investing Activities | 4.03 | 0.01 | 21.12 | |
Cash From Financing Activities | -1.03 | -0.49 | -0.83 | |
Net Change in Cash | -7.62 | -7.8 | -4.65 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review